These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5883214)

  • 61. Further studies on substituted quinazolines and triazines as inhibitors of a methotrexate-insensitive murine dihydrofolate reductase.
    Dedhar S; Freisheim JH; Hynes JB; Goldie JH
    Biochem Pharmacol; 1986 Apr; 35(7):1143-7. PubMed ID: 3964294
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Irreversible enzyme inhibitors. LXXII. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. VI. Derivatives of hydrophobically bonded p-alkyl and p-aralkyl benzoic acids.
    Baker BR; Schwan TJ; Ho BT
    J Pharm Sci; 1967 Jan; 56(1):38-42. PubMed ID: 6030491
    [No Abstract]   [Full Text] [Related]  

  • 63. REACTION OF 1-SUBSTITUTED BIGUANIDE WITH DIETHYL SUCCINATE.
    TAKAGI K; UEDA T
    Chem Pharm Bull (Tokyo); 1964 May; 12():607-14. PubMed ID: 14192424
    [No Abstract]   [Full Text] [Related]  

  • 64. Exploration of 2, 4-diaminopyrimidine and 2, 4-diamino-s-triazine derivatives as potential antifilarial agents.
    Sharma RD; Bag S; Tawari NR; Degani MS; Goswami K; Reddy MV
    Parasitology; 2013 Jul; 140(8):959-65. PubMed ID: 23552564
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The gel-filtration behaviour of dihydrofolate reductases from culture forms of trypanosomatids.
    Gutteridge WE; Jaffe JJ; McCormack JJ
    Biochim Biophys Acta; 1969; 191(3):753-5. PubMed ID: 5363996
    [No Abstract]   [Full Text] [Related]  

  • 66. Irreversible enzyme inhibitors. CLXXVII. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines. II.
    Baker BR; Vermeulen NM
    J Med Chem; 1970 Nov; 13(6):1154-60. PubMed ID: 5479856
    [No Abstract]   [Full Text] [Related]  

  • 67. Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.
    Gangjee A; Lin X; Queener SF
    J Med Chem; 2004 Jul; 47(14):3689-92. PubMed ID: 15214795
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of 4,6-diamino-symm-triazines on nucleic acids of liver and kidney in rats].
    Kuznetsova LI; Okunev VN
    Ukr Biokhim Zh; 1970; 42(5):617-20. PubMed ID: 5511478
    [No Abstract]   [Full Text] [Related]  

  • 69. Inhibition of human dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s. A quantitative structure-activity relationship analysis.
    Hathaway BA; Guo ZR; Hansch C; Delcamp TJ; Susten SS; Freisheim JH
    J Med Chem; 1984 Feb; 27(2):144-9. PubMed ID: 6694162
    [TBL] [Abstract][Full Text] [Related]  

  • 70. AMINO-OXY-DERIVATIVES. V. SOME O-ETHERS OF 2-SUBSTITUTED 4,6-DIAMINO-1,2-DIHYDRO-1-HYDROXY-1,3,5-TRIAZINES.
    MAMALIS P; GREEN J; OUTRED DJ; RIX MJ
    J Chem Soc; 1965 Mar; ():1829-43. PubMed ID: 14288324
    [No Abstract]   [Full Text] [Related]  

  • 71. Comparative biochemistry of dihydrofolate reductase.
    Burchall JJ
    Ann N Y Acad Sci; 1971 Nov; 186():143-52. PubMed ID: 4943573
    [No Abstract]   [Full Text] [Related]  

  • 72. ON THE MECHANISM OF FOLIC ACID REDUCTASE INHIBITION.
    COLLIN R; PULLMAN B
    Biochim Biophys Acta; 1964 Aug; 89():232-41. PubMed ID: 14203171
    [No Abstract]   [Full Text] [Related]  

  • 73. New 2,4-diamino-5-(2',5'-substituted benzyl)pyrimidines as potential drugs against opportunistic infections of AIDS and other immune disorders. Synthesis and species-dependent antifolate activity.
    Rosowsky A; Forsch RA; Sibley CH; Inderlied CB; Queener SF
    J Med Chem; 2004 Mar; 47(6):1475-86. PubMed ID: 14998335
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Crystallographic and molecular-orbital studies on the geometry of antifolate drugs.
    Hunt WE; Schwalbe CH; Bird K; Mallinson PD
    Biochem J; 1980 May; 187(2):533-6. PubMed ID: 6893149
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of dihydrofolate reductase. 3. 4.6-Diamino-1,2-dihydro-2,2-dimethyl-1-(2-substituted-phenyl)-s-triazine inhibition of bovine liver and mouse tumor enzymes.
    Kim KH; Dietrich SW; Hansch C; Dolnick BJ; Bertino JR
    J Med Chem; 1980 Nov; 23(11):1248-51. PubMed ID: 7452676
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [A new determination method of dihydrofolate reductase using ( 3 H) dihydrofolic acid].
    Schalhorn A; Wilmanns W
    Hoppe Seylers Z Physiol Chem; 1972 Jul; 353(7):1069-74. PubMed ID: 4403737
    [No Abstract]   [Full Text] [Related]  

  • 77. Dihydrofolate reductase deficiency causing megaloblastic anemia in two families.
    Tauro GP; Danks DM; Rowe PB; Van der Weyden MB; Schwarz MA; Collins VL; Neal BW
    N Engl J Med; 1976 Feb; 294(9):466-70. PubMed ID: 1060915
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Irreversible enzyme inhibitors. 118. Hydrophobic bonding to dihydrofolic reductase. XII. Further comparisons with the enzyme from Walker 256 rat tumor and rat liver.
    Baker BR; Johnson MA
    J Med Chem; 1968 May; 11(3):486-8. PubMed ID: 5241407
    [No Abstract]   [Full Text] [Related]  

  • 79. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
    Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
    Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
    [TBL] [Abstract][Full Text] [Related]  

  • 80. QSAR analysis of 2,4-diaminopyrido[2,3-d]pyrimidines and 2,4-diaminopyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors.
    Jain P; Soni LK; Gupta AK; Kashkedikar SG
    Indian J Biochem Biophys; 2005 Oct; 42(5):315-20. PubMed ID: 23923540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.